Article Type
Changed
Wed, 02/13/2019 - 10:02
Display Headline
Raloxifene: A new choice for treating and preventing osteoporosis
Article PDF
Author and Disclosure Information

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Angelina V. Ciaccia, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Mayme Wong, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Michael W. Draper, MD, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Address: Angelo A. Licata, MD, PhD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Licata has received grant support from Eli Lilly and Company, which manufactures raloxifene.

Drs. Ciaccia, Wong, and Draper are employees of Eli Lilly and Company.

Issue
Cleveland Clinic Journal of Medicine - 67(4)
Publications
Topics
Page Number
273-280
Sections
Author and Disclosure Information

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Angelina V. Ciaccia, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Mayme Wong, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Michael W. Draper, MD, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Address: Angelo A. Licata, MD, PhD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Licata has received grant support from Eli Lilly and Company, which manufactures raloxifene.

Drs. Ciaccia, Wong, and Draper are employees of Eli Lilly and Company.

Author and Disclosure Information

Angelo A. Licata, MD, PhD
Department of Endocrinology, Cleveland Clinic

Angelina V. Ciaccia, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Mayme Wong, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Michael W. Draper, MD, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Address: Angelo A. Licata, MD, PhD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Licata has received grant support from Eli Lilly and Company, which manufactures raloxifene.

Drs. Ciaccia, Wong, and Draper are employees of Eli Lilly and Company.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(4)
Issue
Cleveland Clinic Journal of Medicine - 67(4)
Page Number
273-280
Page Number
273-280
Publications
Publications
Topics
Article Type
Display Headline
Raloxifene: A new choice for treating and preventing osteoporosis
Display Headline
Raloxifene: A new choice for treating and preventing osteoporosis
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media